Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus

NVR 3-778 is the first capsid assembly modulator (CAM) that has demonstrated antiviral activity in hepatitis B virus (HBV)-infected patients. NVR 3-778 inhibited the generation of infectious HBV DNA-containing virus particles with a mean antiviral 50% effective concentration (EC(50)) of 0.40 µM in H...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Angela M., Espiritu, Christine, Vogel, Robert, Ren, Suping, Lau, Vincent, Kelly, Mollie, Kuduk, Scott D., Hartman, George D., Flores, Osvaldo A., Klumpp, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325219/
https://www.ncbi.nlm.nih.gov/pubmed/30373799
http://dx.doi.org/10.1128/AAC.01734-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325219/
https://www.ncbi.nlm.nih.gov/pubmed/30373799
http://dx.doi.org/10.1128/AAC.01734-18

Ejemplares similares